The high cost of new cancer immunotherapy drugs

The country's top Cancer research organisation is urging the government to step in and fast track the funding of a new generation of immunotherapy cancer drugs, which are being called a revolution in cancer therapy. Professor Rod Dunbar is the director of the Maurice Wilkins centre of research excellence - which draws together all of this country's expertise in the field of cancer therapeutics. Chief executive of the Government's Drug buying agency, Pharmac